Viewing Study NCT01077505


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-06-22 @ 5:05 PM
Study NCT ID: NCT01077505
Status: COMPLETED
Last Update Posted: 2017-06-14
First Post: 2010-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pharmacokinetics View
None GSK716155 View
None Brevicon View
None albiglutide View
None healthy female volunteers View
None oral contraceptive View